Global (phospho)proteomics analysis of EGFR inhibitor drug tolerance and resistance mechanisms in cell-based models of non-small cell lung cancer (2028)
Attributed to:
Understanding complexity of post-translation modifications by enhancing UK capability for top-down proteomics
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17638/03182355
Publication URI: https://livrepository.liverpool.ac.uk/id/eprint/3182355
Type: Other